Stellaromics Raises $80M in Series B Funding

other

Summary

The company intends to use the funds to support the development and commercialization of Pyxa, its 3D spatial biology platform. Led by CEO Todd Dickinson, Stellaromics specializes in 3D spatial multi-omics. Its Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and molecules within thick tissue samples based on its STARmap and RIBOmap technologies. The system is available for order now, with an early access program already fully subscribed and set to launch in the second half of 2025. To support researchers interested in generating pilot data for a Pyxa system, Stellaromics offers a dedicated services program.

Classifications

industries
No industries detected
applications
No applications detected

AskAI Classifications

Labels
No AI classifications detected

Linked Companies